American Health Assistance Foundation Report issue

Foundation Phase 3 Phase 4

Organization Overview

First Clinical Trial
2000
NCT00432081
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2003

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

amphetamine (Adderall) (1 trial)

methylphenidate (ritalin) (1 trial)

Drugs in Phase 3 Trials (1)

indomethacin (indocin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3